Spots Global Cancer Trial Database for F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
Official Title: Phase III Study of F-18-PSMA-1007 vs F-18-Fluorocholine PET to Compare the Detection Rate of Prostate Cancer Lesions in Patients With Biochemical Recurrence After Previous Definitive Treatment for Localized Prostate Cancer
Study ID: NCT04102553
Study Description
Brief Summary: This study evaluates the diagnostic performance and safety of F-18-PSMA-1007 and F-18-Fluorocholine PET/CT imaging in patients with suspected recurrence of prostate cancer after previous definitive treatment.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Centre Jean Perrin Clermont-Ferrand, Clermont-Ferrand, , France
Centre Léon Bérard LUMEN, Lyon, , France
Hôpitaux de Brabois (Vandoeuvre-les-Nancy), Nancy, , France
Hôpital Européen Georges-Pompidou, Paris, , France
Hôpital Tenon, Paris, , France
Hospices Civils de Lyon, Pierre-Bénite, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
